Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Constipation and digestive discomfort Constipation on tirzepatide is the second most common gastrointestinal complaint after nausea
The graphic below is from CMS (you must check off all 4 boxes to qualify)
Despite setting expectations before patients start GLP-1s, Thiara says many still believe the drugs will enable them to reach their ideal weight
In the key Phase 3 ATTAIN-1 trial published in the New England Journal of Medicine in 2025, once-daily orforglipron 36 mg produced mean body weight reductions of 11.2% at 72 weeks in adults with obesity, with nearly 55% of participants achieving at least 10% weight loss and 36% achieving 15% or more
Infertility can also occur in individuals with insufficient B12
US$ 22.70
US$ 28.85
US$ 28.17
US$ 20.80
